| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 7.74K | 1.86K | 350.00 |
| Gross Profit | -14.97K | -13.44K | -19.88K | -25.96K | -31.48K | -5.85K |
| EBITDA | -1.30M | -1.30M | -927.00K | -3.08M | -1.07M | -708.54K |
| Net Income | -1.31M | -1.32M | -946.00K | -993.47K | -1.10M | -714.74K |
Balance Sheet | ||||||
| Total Assets | 1.21M | 1.71M | 177.28K | 6.42M | 5.29M | 3.93M |
| Cash, Cash Equivalents and Short-Term Investments | 1.16M | 1.66M | 82.16K | 594.56K | 1.51M | 1.42M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 130.99K | 162.37K | 94.40K | 240.84K | 356.84K | 480.95K |
| Stockholders Equity | 1.08M | 1.55M | 82.89K | 6.18M | 4.94M | 3.45M |
Cash Flow | ||||||
| Free Cash Flow | -775.00 | -1.22M | -914.12K | -3.09M | -2.48M | -2.08M |
| Operating Cash Flow | -1.16K | -1.22M | -914.12K | -975.47K | -1.07M | -710.38K |
| Investing Cash Flow | 0.00 | 0.00 | 28.57K | -2.12M | -1.30M | -1.37M |
| Financing Cash Flow | 1.62K | 2.79M | 373.15K | 2.18M | 2.46M | 3.36M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
51 Neutral | AU$9.16M | -2.78 | -41.50% | ― | ― | -6.38% | |
46 Neutral | AU$5.05M | -3.72 | -9.21% | ― | ― | 54.74% | |
44 Neutral | AU$5.95M | ― | -161.53% | ― | ― | ― | |
43 Neutral | AU$8.24M | -2.00 | -91.16% | ― | ― | 56.90% | |
41 Neutral | AU$2.76M | -0.23 | -240.83% | ― | ― | 55.05% | |
36 Underperform | AU$8.32M | -0.80 | -145.66% | ― | ― | 34.61% |
Peako Limited announced a change in the director’s interest, specifically regarding Dr. Paul Anthony Kitto. On November 21, 2025, Dr. Kitto disposed of 1,000,000 options that were exercisable at $0.20, which expired on the same date. This change reflects the expiry of unlisted options, and the company has updated its records accordingly.
Peako Limited, an ASX-listed company, announced the results of its annual general meeting held on November 24, 2025. All resolutions, including the special resolution for a 10% placement capacity, were passed. This indicates strong shareholder support and may enhance the company’s financial flexibility.
Peako Limited’s quarterly report highlights its ongoing exploration activities in the East Kimberley region, particularly focusing on the Wirana tenement. The company conducted a desktop geological review to enhance understanding of mineral prospects and is planning reconnaissance and ground validation. Additionally, Peako is assessing opportunities in its application area adjacent to the Brockman Rare-Earths Project, Australia’s largest heavy rare-earths project. The company is also exploring new project opportunities in precious and base metals to complement its existing projects and enhance shareholder value.
Peako Limited has announced its 2025 Annual General Meeting (AGM) for shareholders, scheduled to take place on November 24, 2025, in Melbourne. The company has opted to distribute the Notice of Meeting digitally, encouraging shareholders to vote via proxy by November 22, 2025, and submit questions in advance. This move highlights Peako Limited’s commitment to efficient communication and shareholder engagement, potentially impacting its operational transparency and stakeholder relations.
Peako Limited has announced its Annual General Meeting to be held on November 24, 2025, in Melbourne. The meeting will cover the company’s financial statements for the year ending June 30, 2025, and include resolutions on adopting the remuneration report, re-electing Raewyn Clark as a director, and approving a 10% placement capacity under Listing Rule 7.1A. The resolutions require varying levels of shareholder approval, with specific voting exclusions applicable to certain resolutions.
Peako Limited has announced a change in the director’s interest, specifically regarding Raewyn Louise Clark, who has disposed of 80,000 options that were exercisable at $0.05. This change reflects the expiry of unlisted options, leaving her with 1,120,000 fully paid ordinary shares and 224,000 options exercisable at $0.0075. The announcement indicates a routine adjustment in the director’s holdings, with no immediate impact on the company’s operations or market position.
Peako Limited has announced the cessation of a significant number of securities, specifically 71,727,848 options that expired without exercise or conversion as of September 30, 2025. This cessation of securities may impact the company’s capital structure and could influence investor perceptions and market positioning.